Related Experiment Video

Updated: Jun 5, 2025

An Optimized Single-Molecule Pull-Down Assay for Quantification of Protein Phosphorylation
07:45

An Optimized Single-Molecule Pull-Down Assay for Quantification of Protein Phosphorylation

Published on: June 6, 2022

2.8K

Modulating Phosphorylation by Proximity-Inducing Modalities for Cancer Therapy

Qiuyue Zhang1,2, Jia Yu1,2, Qidong You1,2

  • 1State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China.

Journal of Medicinal Chemistry
|December 9, 2024
PubMed

Insights

New heterobifunctional molecules precisely regulate protein phosphorylation, offering a promising strategy for cancer therapy by targeting aberrant phosphorylation. These novel approaches aim to overcome limitations of traditional modulators for improved drug design.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Abnormal protein phosphorylation is a hallmark of various diseases, especially cancer.
  • Traditional small-molecule kinase/phosphatase modulators face challenges in achieving precise phosphorylation control.
  • Heterobifunctional molecules offer a novel approach for targeted phosphorylation regulation.

Purpose of the Study:

  • To review drug targets with aberrant phosphorylation in cancer.
  • To highlight the therapeutic potential of correcting protein phosphorylation in cancer.
  • To explore the design strategies and features of emerging heterobifunctional molecules for phosphorylation regulation.

Main Methods:

  • Literature review of aberrant phosphorylation targets in cancer.
  • Analysis of reported heterobifunctional molecules (e.g., PHICSs, PHORCs) for phosphorylation regulation.
  • Systematic elaboration of the link between aberrant phosphorylation and cancer.

Main Results:

  • Identified key drug targets with aberrant phosphorylation in various cancers.
  • Demonstrated the potential of heterobifunctional molecules in recruiting kinases or phosphatases to specific proteins.
  • Highlighted current design strategies and characteristics of these novel molecular agents.

Conclusions:

  • Heterobifunctional molecules represent a significant advancement in targeting aberrant phosphorylation for cancer therapy.
  • Further research into these molecules could overcome existing challenges and pave the way for new drug development.
  • Precise phosphorylation regulation holds promise for innovative cancer treatment strategies.

More Related Videos

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

7.9K
Oligopeptide Competition Assay for Phosphorylation Site Determination09:16

Oligopeptide Competition Assay for Phosphorylation Site Determination

Published on: May 18, 2017

8.4K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
49.9K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.8K